From the Oncomine microarray public database analysis for human tumors [39], corroborating the results described above, Mxd1 seems to be reduced in melanoma cells and in metastatic cells, while Myc target genes are increased in cutaneous melanoma and seem to be associated with a poor prognosis (Figure 7). The gene discussed is MYC; the disease is melanoma.